Harbour

Harbour BioMed, a platform-based biopharmaceutical company focused on innovative drug R&D, leverages its proprietary Harbour Mice® antibody technology platform to develop biotherapeutics with significant clinical value across multiple therapeutic areas, including immunology, oncology, metabolism, and the central nervous system.